Summary
The UK government plans to establish an independent, non-profit AI Biosecurity Lab, backed by £100 million in government funding and up to £200 million in company commitments. Its initial goals are to improve early detection of biological threats and speed work on medical countermeasures.
The UK government has announced plans for an independent, non-profit AI Biosecurity Lab (AIBL), backed by £100 million in government funding and up to £200 million in commitments from OpenAI and Anthropic. The organisation is intended to apply frontier AI to two initial priorities: detecting emerging biological threats earlier and accelerating the development of vaccines, treatments and other medical countermeasures.
The announcement, published on 24 October 2026, sets out the lab’s mission and planned partnerships. It describes capabilities the organisation aims to develop, rather than reporting deployed systems or measured results.
What the lab is intended to do
AI can assist biological research, including work to understand diseases and develop medical countermeasures. The same capabilities can also create biological risks or lower barriers to harmful activity, the government says. AIBL is being established to address both sides of that challenge: using AI to support public-health preparedness while strengthening the ability to prevent, detect and respond to biological threats.
Its initial work is expected to focus on earlier detection of emerging threats and on accelerating the discovery, development and testing of vaccines, treatments and other countermeasures. The government says the lab will work with national biosecurity centres and the life-sciences sector, with the aim of translating AI research into practical capabilities. These are intended outcomes; the announcement does not describe completed tools or operational results.
Funding, partners and oversight
The funding combines £100 million from the government with up to £200 million in commitments from OpenAI and Anthropic. The company commitments are described in forms including compute and model credits, trusted access to AI models and technical support. OpenAI will provide £100 million in compute and model credits, alongside trusted access to its most capable relevant models through its Rosalind Biodefense programme. Anthropic will provide up to £100 million in model credits, trusted model access and dedicated technical support.
Google DeepMind scientists and biosecurity experts will work with AIBL on research collaborations and will look to provide trusted access to frontier Gemini and specialised science models. UK company Basecamp Research will contribute access to its AI-biology models, capabilities and technical expertise.
AIBL will operate as an independent non-profit and work with public-sector bodies, academic institutions and industry partners in the UK and internationally. The National AI Biosecurity Initiative brings together the lab with the UK Health Security Agency, the Animal and Plant Health Agency, the Defence Science and Technology Laboratory and the life-sciences sector. The lab will also work with the Medicines and Healthcare products Regulatory Agency on health-emergency preparation and the regulation of AI-designed medicines. A scientific advisory committee is planned, with further details to be announced.